Cytoprotective protein C pathways and implications for stroke and neurological disorders
Related Experiment Video
Updated: Jun 4, 2026

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
Published on: December 15, 2023
Berislav V Zlokovic1, John H Griffin
1Center for Neurodegenerative and Vascular Brain Disorders, Department of Neurological Surgery, University of Rochester Medical Center, Rochester, New York, USA. berislav_zlokovic@urmc.rochester.edu
Abstract:
Recent studies indicate that single-action-single-target agents are unlikely to cure CNS disorders sharing a pathogenic triad consisting of vascular damage, neuronal injury/neurodegeneration and neuroinflammation. Here we focus on a recent example of a multiple-action-multiple-target approach for CNS disorders based on newly discovered biological properties of activated protein C (APC), an endogenous plasma protease with antithrombotic, cytoprotective and anti-inflammatory activities in the CNS. We propose that APC-mediated signaling through the protease activated receptor-1 (PAR1) can favorably regulate multiple pathways within the neurovascular unit in non-neuronal cells and neurons during acute or chronic CNS insults, leading to stabilization of the blood-brain barrier (BBB), neuroprotection and control of neuroinflammation. Although much remains to be understood regarding the biology of APC, preclinical studies suggest that APC has promising applications as disease-modifying therapy for ischemic stroke and other neuropathologies whose underlying pathology involves deficits in the vasculo-neuronal-inflammatory triad.
Insights
Activated protein C (APC), a protease, shows promise for treating CNS disorders by targeting vascular damage, neuronal injury, and neuroinflammation. Its multi-action approach offers potential disease-modifying therapies for conditions like ischemic stroke.
Area of Science:
- Neuroscience
- Pharmacology
- Vascular Biology
Background:
- Central nervous system (CNS) disorders often involve a triad of vascular damage, neuronal injury/neurodegeneration, and neuroinflammation.
- Single-action agents are insufficient for treating complex CNS pathologies.
Purpose of the Study:
- To explore the potential of activated protein C (APC) as a multiple-action-multiple-target therapeutic for CNS disorders.
- To investigate APC's biological properties and signaling pathways in the context of neurovascular and inflammatory processes.
Main Methods:
- Focus on newly discovered biological properties of activated protein C (APC).
- Examined APC-mediated signaling through protease-activated receptor-1 (PAR1).
- Evaluated effects on the neurovascular unit in preclinical models of CNS insults.
Main Results:
- APC exhibits antithrombotic, cytoprotective, and anti-inflammatory activities in the CNS.
- APC signaling via PAR1 favorably regulates pathways in the neurovascular unit.
- Demonstrated potential for blood-brain barrier (BBB) stabilization, neuroprotection, and control of neuroinflammation.
Conclusions:
- Activated protein C (APC) presents a promising disease-modifying therapeutic strategy for CNS disorders.
- APC's multi-target approach addresses the vascular, neuronal, and inflammatory components of neuropathologies.
- Further research into APC biology is warranted for its application in conditions like ischemic stroke.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology
The Blood-brain Barrier
Ischemic Stroke l: Introduction
